1717 K Street NW, Suite 900

Washington, DC 20006-5349

(877) 363-6376

HELPLINE

NEWS

Meet the Meso Experts: Identification of Biomarkers for an Early-Diagnosis Breath Test

Doctor with glasses and gray hair

On Wednesday, July 24, 2019, at 8:00 PM EDT, the Meso Foundation’s Meet the Mesothelioma Experts live broadcast will feature Michael Harbut, MD. 

Dr. Harbut will discuss his new research project which seeks to identify markers for mesothelioma using a non-invasive technique which samples organic compounds in the breath of test subjects. If successful, Dr. Harbut’s project will make it easier to screen individuals at risk for mesothelioma through a breath test, thus more quickly diagnosing, and ultimately treating, patients. 

This live broadcast is open and appropriate for all members of the mesothelioma community including patients, families, medical professionals and anyone else interested in learning more. There is no charge, but we do ask that you RSVP in order to receive the call-in phone number.

About the Speaker

Michael R. Harbut, MD is a clinical professor of medicine at Michigan State University, and the Medical Advisor to the International Heat and Frost Insulators and Allied Workers Union. He is co-author of the most recent diagnostic criteria for asbestos-related diseases for the American Thoracic Society. He is past chair of the Occupational and Environmental Medicine section of the American College of Chest Physicians.

Dr. Harbut’s research team has discovered the probable cause of intractable pleuritic pain in asbestos exposed patients and his group has worked in the development of two mesothelioma tumor markers.  He also conducted the world’s largest study of lung disease in Ironworkers.

As part of the Meet the Mesothelioma Experts (MTME) series, the Meso Foundation invites specialists in the field of mesothelioma to discuss their current research interests as well as promising developments in the treatment of mesothelioma.

Interested in participating in our MTME as a guest speaker? Contact us at [email protected] or 703-879-3797.

Also...

In Other News

Share:

Facebook
Twitter
LinkedIn